Literature DB >> 1379274

Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring?

R F Taylor1, L Dalla Costa, M E Kaufmann, T L Pitt, M E Hodson.   

Abstract

Ribotyping of 25 isolates of Pseudomonas cepacia taken from the sputum of 21 adults with cystic fibrosis (CF) who were registered at the Royal Brompton Hospital between 1987 and 1991, revealed that seven patients (33.3%) shared strains of a similar ribotype pattern with others, while 14 patients (63.7%) harboured strains unique to each individual. Constancy of sputum strain carriage was seen in two of three patients sampled twice over a 3-month period. Although no evidence for patient-to-patient transmission of P. cepacia within this group of patients was found, the fact that one third of CF patients shared strains of the same ribotype with others, suggests that nosocomial acquisition of this organism may have occurred.

Entities:  

Mesh:

Year:  1992        PMID: 1379274     DOI: 10.1016/0195-6701(92)90076-x

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Pseudomonas cepacia in cystic fibrosis.

Authors:  D E Stableforth; D L Smith
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 2.  Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.

Authors:  E H Bingen; E Denamur; J Elion
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

3.  Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.

Authors:  G Amalfitano; E Tonolli; F Favari; C Perazzoli; G Cazzola; G Mastella; I Piacentini
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

4.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.

Authors:  E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.

Authors:  M L Whiteford; J D Wilkinson; J H McColl; F M Conlon; J R Michie; T J Evans; J Y Paton
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

7.  Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease.

Authors:  C Kooi; A Cox; P Darling; P A Sokol
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 8.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.